| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 419,767 | | Cost of Revenue |
-
| | | Gross Profit | 419,767 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 399,720 | | Non Recurring |
-
| | Others | 1,253 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 18,794 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| | Earnings Before Interest And Taxes | 18,794 | | Interest Expense |
-
| | Income Before Tax | 18,794 | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | 18,794 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 18,794 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $18,794 |
|
0.51% Nasdaq 
Income Statement
